1. Home
  2. ENZ

as 12-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical Specialities

Nasdaq

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Founded: 1976 Country:
United States
United States
Employees: N/A City: FARMINGDALE
Market Cap: 56.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 198.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
14.27%
Dividend Payout Frequency: N/A
EPS: -0.46 EPS Growth: N/A
52 Week Low/High: $0.68 - $1.50 Next Earning Date: 12-16-2024
Revenue: $30,314,000 Revenue Growth: 2.72%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

ENZ Daily Stock ML Predictions

Share on Social Networks: